Mainsail Asset Management LLC Has $309,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Mainsail Asset Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 590 shares of the healthcare conglomerate’s stock after purchasing an additional 40 shares during the period. Mainsail Asset Management LLC’s holdings in UnitedHealth Group were worth $309,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Citizens National Bank Trust Department grew its position in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH increased its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $515,000. Full Sail Capital LLC increased its holdings in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 2.5%

UNH opened at $250.74 on Monday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market cap of $227.46 billion, a PE ratio of 10.86, a price-to-earnings-growth ratio of 1.62 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm’s fifty day moving average is $291.78 and its two-hundred day moving average is $405.18.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the firm posted $6.80 earnings per share. The firm’s revenue was up 12.9% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.5%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Morgan Stanley cut their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Truist Financial lowered their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a research report on Wednesday, July 16th. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Finally, Wolfe Research dropped their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $366.52.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.